Levosimendan Reduces Lung Injury in a Canine Model of Cardiopulmonary Bypass

BACKGROUND AND OBJECTIVES: To explore the lung-protective effect of levosimendan (LS) during cardiopulmonary bypass in a canine model by determining the wet/dry weight (W/D) ratio of lung tissue, malonaldehyde (MDA) and superoxide dismutase (SOD) concentrations, and performing a histological evaluat...

Descripción completa

Detalles Bibliográficos
Autores principales: Feng, Junbo, Liu, Haiyuan, Chen, Jiayi, Wang, Jiyuan, Liu, Zhuang, Ge, Shenglin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Society of Cardiology 2016
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4891605/
https://www.ncbi.nlm.nih.gov/pubmed/27275177
http://dx.doi.org/10.4070/kcj.2016.46.3.402

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4891605/
https://www.ncbi.nlm.nih.gov/pubmed/27275177
http://dx.doi.org/10.4070/kcj.2016.46.3.402

Ejemplares similares